CDKN2A(p16) mRNA decreased expression is a marker of poor...

CDKN2A(p16) mRNA decreased expression is a marker of poor prognosis in malignant high-grade glioma

Sibin, M. K., Bhat, Dhananjaya I., Narasingarao, K. V. L., Lavanya, Ch., Chetan, G. K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
36
Language:
english
Journal:
Tumor Biology
DOI:
10.1007/s13277-015-3480-5
Date:
October, 2015
File:
PDF, 352 KB
english, 2015
Conversion to is in progress
Conversion to is failed